Pharmacokinetics and Pharmacodynamics of Extended‐Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open‐Label Study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Pub Date : 2019-10-22 DOI:10.1002/phar.2332

C. Philpott, C. Droege, M. Droege, D. Healy, Joshua D. Courter, N. Ernst, N. Harger, M. Foertsch, J. Winter, Kristen E. Carter, Suzanne Van Fleet, K. Athota, E. Mueller

引用次数: 11

Abstract

To evaluate extended‐infusion (EI) cefepime pharmacokinetics (PK) and pharmacodynamic target attainment in critically ill patients receiving continuous venovenous hemofiltration (CVVH) or continuous venovenous hemodialysis (CVVHD).

查看原文本刊更多论文

接受持续肾脏替代治疗的危重患者长期输注头孢吡肟的药代动力学和药效学:一项前瞻性、开放标签研究

评估延长输注(EI)头孢吡肟药代动力学(PK)和危重患者接受持续静脉静脉血液滤过(CVVH)或持续静脉静脉血液透析(CVVHD)的药效学目标实现情况。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

自引率

0.00%

发文量